Evergreening refers to strategies extending patent life by making minor modifications to existing drugs, like altering dosages or delivery methods. This practice delays generic competition, allowing pharmaceutical companies to maintain high prices and profits. Patients and healthcare systems often bear the burden, facing limited access to affordable medications while companies benefit from prolonged market exclusivity.
Get alerts when this topic surges in newsletters. Free to start.
Sign up freeExplore more trends:Trending Topics ·AI Trends ·Business Trends ·Finance Trends ·Technology Trends